comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists Risk of major adverse events stroke associated treatment with or the dual GIP/GLP-1 receptor agonist for type 2 diabetes: A systematic review and meta-analysis Frontiers | Clinical perspectives on

This depends on your goals and your metabolic health

Tirzepatide Dual Agonist GLP-1 + GIP A fatty-acid-modified dual incretin agonist that crushes semaglutide delivering up to 20.9% weight loss with fewer side effects and complete food-noise silence.

NIDDK-Tirzepatide Nano Microneedle Patch is a multi-functional treatment solution that primarily helps with weight loss by suppressing appetite and delaying gastric emptying

So youre going to Taco Bell

Baton Rouge, LA obesity expert and senior director of clinical product strategy at Ro, Raoul Manalac, MD says the approval may lead to greater insurance coverage and gives patients another option to help achieve their weight and health goals